NCT05407766View on ClinicalTrials.gov

Mesenchymal Stem Cells (MSCs) for Perianal Fistula

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

August 31, 2024

Conditions
Rectal Fistula
Interventions
BIOLOGICAL

OSSM-001

Single injection of OSSM-001 at dose of 100M or 300M cells

OTHER

Placebo

Single injection of placebo (saline)

Sponsors
All Listed Sponsors
lead

Ossium Health, Inc.

INDUSTRY

NCT05407766 - Mesenchymal Stem Cells (MSCs) for Perianal Fistula | Biotech Hunter | Biotech Hunter